Hon Ibrahim Ssemujju Nganda: There is also investment in Dei Pharmaceutical. According to the Auditor General Report, we have so far spent UGX 723 billion in buying shares in a company the Auditor General says whose value is not established.

 #NBSMorningBreeze #NBSUpdates
#nbsmorningbreeze
#NBSMorningBreeze #NBSUpdates